BrightSpring Health Q2 2024 Adj. EPS $0.10 Misses $0.17 Estimate, Sales $2.730B Beat $2.613B Estimate
Portfolio Pulse from Benzinga Newsdesk
BrightSpring Health (NASDAQ:BTSG) reported Q2 2024 earnings per share (EPS) of $0.10, missing the analyst estimate of $0.17 by 41.18%. However, the company reported sales of $2.730 billion, beating the estimate of $2.613 billion by 4.46%. EPS decreased by 33.33% year-over-year, while sales increased by 25.98%.
August 02, 2024 | 10:06 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BrightSpring Health's Q2 2024 EPS missed estimates significantly, which could negatively impact investor sentiment. However, the strong sales performance might offset some of the negative impact.
The significant miss on EPS is likely to weigh heavily on investor sentiment, potentially leading to a short-term decline in the stock price. However, the better-than-expected sales performance may provide some support, resulting in mixed market reactions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100